SMTL ID : 7vm4.1

Crystal structure of uPA in complex with nafamostat

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.01 Å

Oligo State

monomer

Ligands

1 x GBS: 4-carbamimidamidobenzoic acid(Covalent)

GBS.1: 14 residues within 4Å: Chain A: D.192, S.193, C.194, Q.195, G.196, S.198, V.216, S.217, W.218, G.219, R.220, G.221, C.222, G.229 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:V.216 Hydrogen bonds: A:S.193, A:S.193, A:G.196, A:D.197, A:S.198, A:R.220 Water bridges: A:D.192 Salt bridges: A:D.192

2 x PGE: TRIETHYLENE GLYCOL(Non-functional Binders)

PGE.2: 3 residues within 4Å: Chain A: V.27, N.67, L.149 1 PLIP interactions: 1 interactions with chain A Water bridges: A:N.67 PGE.3: 8 residues within 4Å: Chain A: G.132, K.160, L.161, I.162, A.185, D.186, P.187, W.189 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zhou, Y. et al., Structural study of the uPA-nafamostat complex reveals a covalent inhibitory mechanism of nafamostat. Biophys.J. (2022)

Release Date

2022-10-12

Peptides

Urokinase-type plasminogen activator: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
U

Urokinase-type plasminogen activator

Related Entries With Identical Sequence